{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T06:35:24Z","timestamp":1792564524749,"version":"4.5.0"},"reference-count":6,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Frontline Gastroenterol"],"accepted":{"date-parts":[[2020,9,23]]},"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p>Recent interim guidance from the British Society of Gastroenterology, aligned to historical paediatric practice, advises a no-biopsy protocol (NBP) for adults with high anti-tissue transglutaminase (tTG-IgA) titres and other clinical factors. A 7-year retrospective review identified 433 patients with positive tTG-IgA. Of these 433, 98 (23%) fulfilled the high titre criteria for an NBP which may have reduced endoscopic burden on the service. A high titre versus low titre translated in a 95% versus 75% histological confirmation of coeliac disease (p&lt;0.01). The addition of anti-endomysial antibody analyses impacted minimally on these predictive rates. Our data support an NBP approach for selected patients. Of concern, however, was the finding that a third of patients with positive titres were not referred for a biopsy despite national guidance at the time advocating it. A clear message needs to be transmitted that the NBP is only for those with high titre, as opposed to any tTG-IgA positivity.<\/jats:p>","DOI":"10.1136\/flgastro-2020-101624","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T17:20:51Z","timestamp":1602004851000},"page":"73-76","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":28,"title":["No-biopsy pathway following the interim BSG guidance reliably diagnoses adult coeliac disease"],"prefix":"10.1136","volume":"13","author":[{"given":"Richard David","family":"Johnston","sequence":"first","affiliation":[{"name":"Gastroenterology, Torbay Hospital, Torquay, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying Jenny","family":"Chan","sequence":"additional","affiliation":[{"name":"Paediatrics, Torbay Hospital, Torquay, UK"},{"name":"Peninsula Medical School, University of Plymouth, Plymouth, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayyib","family":"Mubashar","sequence":"additional","affiliation":[{"name":"Paediatrics, Torbay Hospital, Torquay, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Robert","family":"Bailey","sequence":"additional","affiliation":[{"name":"Clinical Biochemistry, Torbay Hospital, Torquay, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1267-1269","authenticated-orcid":false,"given":"Siba Prosad","family":"Paul","sequence":"additional","affiliation":[{"name":"Paediatrics, Torbay Hospital, Torquay, UK"},{"name":"Paediatrics, Yeovil District Hospital, Yeovil, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,10,6]]},"reference":[{"key":"2025090709345524000_13.1.73.1","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e31821a23d0"},{"key":"2025090709345524000_13.1.73.2","doi-asserted-by":"crossref","first-page":"A344.1","DOI":"10.1136\/gutjnl-2012-302514d.116","article-title":"PWE-116\u2005Can the new ESPGHAN diagnostic guidelines for coeliac disease be applied to adults?","volume":"61","author":"Wong","year":"2012","journal-title":"Gut"},{"key":"2025090709345524000_13.1.73.3","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s12291-017-0695-9","article-title":"Can high titres of anti tissue transglutaminase antibodies reduce the need for intestinal biopsy for diagnosis of celiac disease?","volume":"33","author":"Bansal","year":"2018","journal-title":"Indian J Clin Biochem"},{"key":"2025090709345524000_13.1.73.4","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1007\/s10620-017-4672-1","article-title":"Application of the Biopsy-Sparing ESPGHAN guidelines for celiac disease diagnosis in adults: a real-life study","volume":"62","author":"Efthymakis","year":"2017","journal-title":"Dig Dis Sci"},{"key":"2025090709345524000_13.1.73.5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MEG.0000000000001613","article-title":"High rates of serology testing for coeliac disease, and low rates of endoscopy in serologically positive children and adults in Israel: lessons from a large real-world database","volume":"32","author":"Guz-Mark","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2025090709345524000_13.1.73.6","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.cgh.2018.09.006","article-title":"Numbers and features of patients with a diagnosis of celiac disease without duodenal biopsy, based on a national survey","volume":"17","author":"Joelson","year":"2019","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Frontline Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/flgastro-2020-101624","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T16:35:04Z","timestamp":1757262904000},"score":1,"resource":{"primary":{"URL":"https:\/\/fg.bmj.com\/lookup\/doi\/10.1136\/flgastro-2020-101624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,6]]},"references-count":6,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12,7]]},"published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1136\/flgastro-2020-101624"],"URL":"https:\/\/doi.org\/10.1136\/flgastro-2020-101624","relation":{},"ISSN":["2041-4137","2041-4145"],"issn-type":[{"value":"2041-4137","type":"print"},{"value":"2041-4145","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,6]]}}}